MKC253 inhalation powder
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MKC253 inhalation powder, covering 2012-06-14 to 2012-06-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study Designed to Determine the Safety and Pharmacological Response ofMKC253 Inhalation Powder in Adults With Type 2 Diabetes Mellitus [Phase 1]